• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫文库分析揭示其在视神经脊髓炎谱系疾病中的临床应用潜力和触发因素。

Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders.

机构信息

From the College of Life Sciences (M., X.J.), University of Chinese Academy of Sciences, Beijing; Department of Neurology (Z.S., L.Z., S.T., H.C., X.W., Q.D., Y.Z., W.L., M.F., H.Z.), West China Hospital, Sichuan University, Chengdu; and City University of Hong Kong (W.Z., S.L.), Shenzhen Research Institute, China.

出版信息

Neurol Neuroimmunol Neuroinflamm. 2023 Jul 6;10(5). doi: 10.1212/NXI.0000000000200134. Print 2023 Sep.

DOI:10.1212/NXI.0000000000200134
PMID:37414573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10326831/
Abstract

BACKGROUND AND OBJECTIVES

Neuromyelitis optica spectrum disorders (NMOSD) is widely recognized as a CNS demyelinating disease associated with AQP4-IgG (T cell-dependent antibody), and its trigger is still unclear. In addition, although the treatment of NMOSD currently can rely on traditional immunosuppressive and modulating agents, effective methods to predict the efficacy of these therapeutics are lacking.

METHODS

In this study, high-throughput T-cell receptor (TCR) sequencing was performed on peripheral blood from 151 pretreatment patients with AQP4-IgG NMOSD and 151 healthy individuals. We compared the TCR repertoire of those with NMOSD with that of healthy individuals and identified TCR clones that were significantly enriched in NMOSD. In addition, we treated 28 patients with AQP4-IgG NMOSD with immunosuppressants and followed up for 6 months to compare changes in NMOSD-specific TCRs (NMOSD-TCRs) before and after treatment. Moreover, we analyzed transcriptome and single-cell B-cell receptor (BCR) data from public databases and performed T-cell activation experiments using antigenic epitopes of cytomegalovirus (CMV) to further explore the triggers of AQP4-IgG NMOSD.

RESULTS

Compared with healthy controls, patients with AQP4-IgG NMOSD had significantly reduced diversity and shorter CDR3 length of TCRβ repertoire. Furthermore, we identified 597 NMOSD-TCRs with a high sequence similarity that have the potential to be used in the diagnosis and prognosis of NMOSD. The characterization of NMOSD-TCRs and pathology-associated clonotype annotation indicated that the occurrence of AQP4-IgG NMOSD may be associated with CMV infection, which was further corroborated by transcriptome and single-cell BCR analysis results from public databases and T-cell activation experiments.

DISCUSSION

Our findings suggest that the occurrence of AQP4-IgG NMOSD may be associated with CMV infection. In conclusion, our study provides new clues to uncover the causative factors of AQP4-IgG NMOSD and provides a theoretical foundation for treating and monitoring the disease.

摘要

背景与目的

视神经脊髓炎谱系疾病(NMOSD)被广泛认为是一种与水通道蛋白 4 免疫球蛋白 G(T 细胞依赖性抗体)相关的中枢神经系统脱髓鞘疾病,但其发病机制仍不清楚。此外,尽管 NMOSD 的治疗目前可以依赖于传统的免疫抑制和调节药物,但缺乏预测这些治疗方法疗效的有效方法。

方法

本研究对 151 例 AQP4-IgG NMOSD 患者和 151 例健康个体的外周血进行了高通量 T 细胞受体(TCR)测序。我们比较了 NMOSD 患者与健康个体的 TCR 谱,确定了在 NMOSD 中明显富集的 TCR 克隆。此外,我们对 28 例 AQP4-IgG NMOSD 患者进行了免疫抑制剂治疗,并进行了 6 个月的随访,以比较治疗前后 NMOSD 特异性 TCR(NMOSD-TCR)的变化。此外,我们分析了公共数据库中的转录组和单细胞 B 细胞受体(BCR)数据,并使用巨细胞病毒(CMV)的抗原表位进行了 T 细胞激活实验,以进一步探讨 AQP4-IgG NMOSD 的触发因素。

结果

与健康对照组相比,AQP4-IgG NMOSD 患者的 TCRβ repertoire 多样性显著降低,CDR3 长度也较短。此外,我们鉴定了 597 个具有高序列相似性的 NMOSD-TCR,它们有可能用于 NMOSD 的诊断和预后。NMOSD-TCR 的特征描述和与病理学相关的克隆型注释表明,AQP4-IgG NMOSD 的发生可能与 CMV 感染有关,这一结论进一步得到了公共数据库转录组和单细胞 BCR 分析结果以及 T 细胞激活实验的证实。

讨论

我们的研究结果表明,AQP4-IgG NMOSD 的发生可能与 CMV 感染有关。总之,我们的研究为揭示 AQP4-IgG NMOSD 的致病因素提供了新的线索,并为治疗和监测该疾病提供了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/91c4edc62ec2/NXI-2023-000037f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/2fc3f4a8f4f5/NXI-2023-000037f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/989b45afb767/NXI-2023-000037f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/1ffc3f3f5002/NXI-2023-000037f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/383ccb35c5cc/NXI-2023-000037f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/e3573d7178b6/NXI-2023-000037f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/91c4edc62ec2/NXI-2023-000037f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/2fc3f4a8f4f5/NXI-2023-000037f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/989b45afb767/NXI-2023-000037f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/1ffc3f3f5002/NXI-2023-000037f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/383ccb35c5cc/NXI-2023-000037f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/e3573d7178b6/NXI-2023-000037f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8321/10326831/91c4edc62ec2/NXI-2023-000037f6.jpg

相似文献

1
Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders.免疫文库分析揭示其在视神经脊髓炎谱系疾病中的临床应用潜力和触发因素。
Neurol Neuroimmunol Neuroinflamm. 2023 Jul 6;10(5). doi: 10.1212/NXI.0000000000200134. Print 2023 Sep.
2
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease.利妥昔单抗治疗视神经脊髓炎谱系疾病和髓鞘少突胶质细胞糖蛋白抗体病的长期疗效和安全性
Neurology. 2022 Nov 29;99(22):e2504-e2516. doi: 10.1212/WNL.0000000000201260. Epub 2022 Aug 31.
3
Targeting the complement system in neuromyelitis optica spectrum disorder.靶向视神经脊髓炎谱系疾病中的补体系统。
Expert Opin Biol Ther. 2021 Aug;21(8):1073-1086. doi: 10.1080/14712598.2021.1884223. Epub 2021 Feb 16.
4
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.迟发性视神经脊髓炎谱系障碍的临床特征
Mult Scler Relat Disord. 2023 Feb;70:104517. doi: 10.1016/j.msard.2023.104517. Epub 2023 Jan 15.
5
Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.水通道蛋白-4 免疫球蛋白 G 阳性视神经脊髓炎谱系疾病中的短节段脊髓炎病变。
JAMA Neurol. 2015 Jan;72(1):81-7. doi: 10.1001/jamaneurol.2014.2137.
6
AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.AQP4-IgG 阳性视神经脊髓炎谱系疾病(NMOSD)合并抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎:病例报告及文献复习。
Mult Scler Relat Disord. 2019 Oct;35:185-192. doi: 10.1016/j.msard.2019.07.008. Epub 2019 Jul 20.
7
The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.补体蛋白在区分 AQP4-IgG 阳性与 MOG-IgG 阳性视神经脊髓炎谱系疾病中的临床价值。
Mult Scler Relat Disord. 2019 Oct;35:1-4. doi: 10.1016/j.msard.2019.06.035. Epub 2019 Jun 29.
8
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.血清 GFAP 和 NfL 作为水通道蛋白-4 抗体阳性视神经脊髓炎谱系疾病的疾病严重程度和预后生物标志物。
J Neuroinflammation. 2021 May 1;18(1):105. doi: 10.1186/s12974-021-02138-7.
9
[Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders].[视神经脊髓炎谱系障碍诊断中血清水通道蛋白-4自身抗体评估的实际问题]
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(7. Vyp. 2):24-31. doi: 10.17116/jnevro202012007224.
10
ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.ABCB1基因多态性影响大剂量静脉注射甲泼尼龙治疗与水通道蛋白4-IgG阳性视神经脊髓炎谱系障碍相关视神经炎的疗效。
J Clin Pharm Ther. 2022 Sep;47(9):1379-1387. doi: 10.1111/jcpt.13675. Epub 2022 Apr 29.

引用本文的文献

1
Immune Repertoires in Various Dermatologic and Autoimmune Diseases.各种皮肤病和自身免疫性疾病中的免疫组库
Genes (Basel). 2024 Dec 11;15(12):1591. doi: 10.3390/genes15121591.
2
Age-Related Dynamics and Spectral Characteristics of the TCRβ Repertoire in Healthy Children: Implications for Immune Aging.健康儿童TCRβ库的年龄相关动态变化及光谱特征:对免疫衰老的启示
Aging Cell. 2025 Apr;24(4):e14460. doi: 10.1111/acel.14460. Epub 2025 Jan 2.
3
Brief research report: WGCNA-driven identification of histone modification genes as potential biomarkers in AQP4-Associated optic neuritis.

本文引用的文献

1
Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.疫苗接种后新诊断的视神经脊髓炎谱系障碍:病例报告与系统评价。
Mult Scler Relat Disord. 2022 Feb;58:103414. doi: 10.1016/j.msard.2021.103414. Epub 2021 Nov 18.
2
Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder.中性粒细胞来源的无细胞 DNA 可触发视神经脊髓炎谱系障碍中的 I 型干扰素特征。
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 24;9(3). doi: 10.1212/NXI.0000000000001149. Print 2022 May.
3
T Cell Repertoire Abnormality in Immunodeficiency Patients with DNA Repair and Methylation Defects.
简短研究报告:基于加权基因共表达网络分析(WGCNA)鉴定组蛋白修饰基因作为水通道蛋白4相关视神经炎的潜在生物标志物
Front Genet. 2024 Aug 22;15:1423584. doi: 10.3389/fgene.2024.1423584. eCollection 2024.
4
Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder.视神经脊髓炎谱系疾病患者的巨细胞病毒和 Epstein-Barr 病毒感染。
J Neurol. 2024 Sep;271(9):6089-6095. doi: 10.1007/s00415-024-12571-2. Epub 2024 Jul 24.
5
Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases.视神经脊髓炎谱系疾病中中枢神经系统炎性脱髓鞘疾病 B 细胞受体的独特特征。
J Neuroinflammation. 2023 Oct 4;20(1):225. doi: 10.1186/s12974-023-02896-6.
免疫缺陷患者中 DNA 修复和甲基化缺陷导致 T 细胞受体异常。
J Clin Immunol. 2022 Feb;42(2):375-393. doi: 10.1007/s10875-021-01178-1. Epub 2021 Nov 25.
4
Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials.有望造福视神经脊髓炎谱系疾病患者——从发病机制到临床试验。
Nat Rev Neurol. 2021 Dec;17(12):759-773. doi: 10.1038/s41582-021-00568-8. Epub 2021 Oct 28.
5
Lung cancer-associated T cell repertoire as potential biomarker for early detection of stage I lung cancer.肺癌相关 T 细胞库作为早期检测 I 期肺癌的潜在生物标志物。
Lung Cancer. 2021 Dec;162:16-22. doi: 10.1016/j.lungcan.2021.09.017. Epub 2021 Sep 28.
6
B-Cell Compartmental Features and Molecular Basis for Therapy in Autoimmune Disease.B 细胞区室特征和自身免疫性疾病治疗的分子基础。
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 31;8(6). doi: 10.1212/NXI.0000000000001070. Print 2021 Nov.
7
Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating Disorders.不同中枢神经系统炎性脱髓鞘疾病患者的血清肽免疫球蛋白G自身抗体反应
Diagnostics (Basel). 2021 Jul 26;11(8):1339. doi: 10.3390/diagnostics11081339.
8
Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder.视神经脊髓炎谱系疾病中的胸腺萎缩和幼稚 CD4 T 细胞内稳态改变。
Front Immunol. 2021 Jul 16;12:645277. doi: 10.3389/fimmu.2021.645277. eCollection 2021.
9
TCRMatch: Predicting T-Cell Receptor Specificity Based on Sequence Similarity to Previously Characterized Receptors.TCRMatch:基于与已鉴定受体的序列相似性预测 T 细胞受体特异性。
Front Immunol. 2021 Mar 11;12:640725. doi: 10.3389/fimmu.2021.640725. eCollection 2021.
10
An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.抗水通道蛋白 4 抗体阳性视神经脊髓炎谱系疾病中,中性粒细胞与淋巴细胞比值升高与预后无关。
Front Immunol. 2021 Feb 23;12:628024. doi: 10.3389/fimmu.2021.628024. eCollection 2021.